Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-039358
Filing Date
2025-02-27
Accepted
2025-02-27 16:59:47
Documents
6
Effectiveness Date
2025-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 d871552ds8.htm S-8 53933
2 EX-5.1 d871552dex51.htm EX-5.1 8445
3 EX-23.1 d871552dex231.htm EX-23.1 1585
4 EX-99.1 d871552dex991.htm EX-99.1 96645
5 EX-FILING FEES d871552dexfilingfees.htm EX-FILING FEES 16549
6 GRAPHIC g871552dsp11.jpg GRAPHIC 8462
  Complete submission text file 0001193125-25-039358.txt   190107
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285358 | Film No.: 25680402
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)